SLC5A5 and thyroid cancer: In our previous study, we found that the uptake of 211At in K1-NIS cells was enhanced using 211At solution treated with ascorbic acid and demonstrated the dose-dependent tumour-suppressive effect of [211At]NaAt solution in NIS-expressing thyroid cancer models [11].